BioXcel Therapeutics, Inc. (BTAI)
$0.17-$0.55 (-76.09%) Today
Richard I. Steinhart - OfficerRichard I. Steinhart - OfficerBioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are-BXCL501, being evaluated as a potential treatment for agitation associated with multiple neurological disorders and BXCL701, an investigational oral innate immune activator for the treatment of aggressive forms of prostate cancer and other solid and liquid tumors. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
https://www.bioxceltherapeutics.comSEC filings for BTAI on EDGAR
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 17,000 | |
| Option exercise | 8 | 648 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
47 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Susan E. Atkins - Director | Grant or award | Stock Option (Right to Buy) | 17,000 | $0.00 | - | |
| Javier Rodriguez - Officer | Option exercise | Common Stock | 35 | - | - | |
| Javier Rodriguez - Officer | Option exercise | Restricted Stock Units | 35 | $0.00 | - | |
| Richard I. Steinhart - Officer | Option exercise | Common Stock | 35 | - | - | |
| Richard I. Steinhart - Officer | Option exercise | Restricted Stock Units | 35 | $0.00 | - | |
| Frank Yocca - Officer | Option exercise | Common Stock | 35 | - | - | |
| Frank Yocca - Officer | Option exercise | Restricted Stock Units | 35 | $0.00 | - | |
| Vimal Mehta - Officer | Option exercise | Common Stock | 219 | - | - | |
| Vimal Mehta - Officer | Option exercise | Restricted Stock Units | 219 | $0.00 | - | |
| Frank Yocca - Officer | Option exercise | Common Stock | 17,500 | - | - | |
| Frank Yocca - Officer | Open-market sale | Common Stock | 6,845 | $1.09 | $7K | |
| Frank Yocca - Officer | Option exercise | Restricted Stock Units | 17,500 | $0.00 | - | |
| Javier Rodriguez - Officer | Option exercise | Common Stock | 17,500 | - | - | |
| Javier Rodriguez - Officer | Open-market sale | Common Stock | 6,560 | $1.08 | $7K | |
| Javier Rodriguez - Officer | Option exercise | Restricted Stock Units | 17,500 | $0.00 | - | |
| Richard I. Steinhart - Officer | Option exercise | Common Stock | 17,500 | - | - | |
| Richard I. Steinhart - Officer | Open-market sale | Common Stock | 6,845 | $1.09 | $7K | |
| Richard I. Steinhart - Officer | Option exercise | Restricted Stock Units | 17,500 | $0.00 | - | |
| Vimal Mehta - Officer | Option exercise | Common Stock | 49,758 | - | - | |
| Vimal Mehta - Officer | Open-market sale | Common Stock | 19,419 | $1.09 | $21K | |
| Vimal Mehta - Officer | Option exercise | Restricted Stock Units | 49,758 | $0.00 | - | |
| Vimal Mehta - Officer | Option exercise | Common Stock | 18,000 | - | - | |
| Vimal Mehta - Officer | Option exercise | Restricted Stock Units | 18,000 | $0.00 | - | |
| Richard I. Steinhart - Officer | Option exercise | Common Stock | 9,000 | - | - | |
| Richard I. Steinhart - Officer | Option exercise | Restricted Stock Units | 9,000 | $0.00 | - | |
| Frank Yocca - Officer | Option exercise | Common Stock | 9,000 | - | - | |
| Frank Yocca - Officer | Option exercise | Restricted Stock Units | 9,000 | $0.00 | - | |
| Javier Rodriguez - Officer | Option exercise | Common Stock | 9,000 | - | - | |
| Javier Rodriguez - Officer | Option exercise | Restricted Stock Units | 9,000 | $0.00 | - | |
| Vimal Mehta - Officer | Option exercise | Common Stock | 164 | - | - | |
| Vimal Mehta - Officer | Option exercise | Common Stock | 219 | - | - | |
| Vimal Mehta - Officer | Option exercise | Restricted Stock Units | 164 | $0.00 | - | |
| Vimal Mehta - Officer | Option exercise | Restricted Stock Units | 219 | $0.00 | - | |
| Richard I. Steinhart - Officer | Option exercise | Common Stock | 33 | - | - | |
| Richard I. Steinhart - Officer | Option exercise | Common Stock | 35 | - | - | |
| Richard I. Steinhart - Officer | Option exercise | Restricted Stock Units | 33 | $0.00 | - | |
| Richard I. Steinhart - Officer | Option exercise | Restricted Stock Units | 35 | $0.00 | - | |
| Javier Rodriguez - Officer | Option exercise | Common Stock | 33 | - | - | |
| Javier Rodriguez - Officer | Option exercise | Common Stock | 35 | - | - | |
| Javier Rodriguez - Officer | Option exercise | Restricted Stock Units | 33 | $0.00 | - | |
| Javier Rodriguez - Officer | Option exercise | Restricted Stock Units | 35 | $0.00 | - | |
| Frank Yocca - Officer | Option exercise | Common Stock | 33 | - | - | |
| Frank Yocca - Officer | Option exercise | Common Stock | 35 | - | - | |
| Frank Yocca - Officer | Option exercise | Restricted Stock Units | 33 | $0.00 | - | |
| Frank Yocca - Officer | Option exercise | Restricted Stock Units | 35 | $0.00 | - | |
| David J. Mack - Director | Option exercise | Common Stock | 1,694 | - | - | |
| David J. Mack - Director | Option exercise | Restricted Stock Units | 1,694 | $0.00 | - | |
| David J. Mack - Director | Option exercise | Common Stock | 1,694 | - | - | |
| David J. Mack - Director | Option exercise | Restricted Stock Units | 1,694 | $0.00 | - | |
| Javier Rodriguez - Officer | Option exercise | Common Stock | 33 | - | - | |
| Javier Rodriguez - Officer | Option exercise | Common Stock | 35 | - | - | |
| Javier Rodriguez - Officer | Option exercise | Restricted Stock Units | 33 | $0.00 | - | |
| Javier Rodriguez - Officer | Option exercise | Restricted Stock Units | 35 | $0.00 | - | |
| Vimal Mehta - Officer | Option exercise | Common Stock | 163 | - | - | |
| Vimal Mehta - Officer | Option exercise | Common Stock | 219 | - | - | |
| Vimal Mehta - Officer | Option exercise | Restricted Stock Units | 163 | $0.00 | - | |
| Vimal Mehta - Officer | Option exercise | Restricted Stock Units | 219 | $0.00 | - | |
| Richard I. Steinhart - Officer | Option exercise | Common Stock | 33 | - | - | |
| Richard I. Steinhart - Officer | Option exercise | Common Stock | 35 | - | - | |
| Richard I. Steinhart - Officer | Option exercise | Restricted Stock Units | 33 | $0.00 | - | |
| Richard I. Steinhart - Officer | Option exercise | Restricted Stock Units | 35 | $0.00 | - | |
| Frank Yocca - Officer | Option exercise | Common Stock | 33 | - | - | |
| Frank Yocca - Officer | Option exercise | Common Stock | 35 | - | - | |
| Frank Yocca - Officer | Option exercise | Restricted Stock Units | 33 | $0.00 | - | |
| Frank Yocca - Officer | Option exercise | Restricted Stock Units | 35 | $0.00 | - | |
| David J. Mack - Director | Option exercise | Common Stock | 1,693 | - | - | |
| David J. Mack - Director | Option exercise | Restricted Stock Units | 1,693 | $0.00 | - | |
| Vimal Mehta - Officer | Grant or award | Restricted Stock Units | 18,000 | $0.00 | - | |
| Richard I. Steinhart - Officer | Grant or award | Restricted Stock Units | 9,000 | $0.00 | - | |
| Javier Rodriguez - Officer | Grant or award | Restricted Stock Units | 9,000 | $0.00 | - | |
| Frank Yocca - Officer | Grant or award | Restricted Stock Units | 9,000 | $0.00 | - | |
| David J. Mack - Director | Option exercise | Common Stock | 1,693 | - | - | |
| David J. Mack - Director | Option exercise | Restricted Stock Units | 1,693 | $0.00 | - | |
| Frank Yocca - Officer | Grant or award | Common Stock | 4,375 | - | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
BioXcel Therapeutics, Inc. (BTAI) had 5 insider filings in the last 90 days, with the most recent on 2026-08-14. The full record for BTAI runs to 47 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of BTAI were filed in the last 90 days.
No insider sales of BTAI were filed in the last 90 days. 18 sales are on record for this company.
This page tracks BTAI Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add BTAI to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
